Paradigm Changing Technologies in Oncology
12 ArticlesBioPharma ×
Pivot to Cash: Bankruptcy & Restructuring in a Distressed Environment
Microbiome: Hope or Hype?
How to Apply the Golden Rule of Research to your Trial Master File
This webinar evaluated the regulations that support GDP, best practices on how document contributors can apply the golden rule of research to their TMF, how to avoid writing too many and unnecessary Note-to-Files (NTFs), and tips on becoming inspection ready and staying that way.
Biotech and Pharma Licensing Negotiations
The Nuts & Bolts of Selecting a Contract Research Organization
This webinar evaluated how to determine internal champions/selection committees, strategic sourcing/procurement workflow/checklist, documentation and regulations, challenges of CRO outsourcing, and best practices to get best value.
Getting Ready for a Biopharma Partnering Deal
What's Hot and What's Not in Oncology Licensing in 2020?
Adoptive Cell Therapy in Solid Tumors
Predictable Failure (And How to Avoid It) for Early-Stage Life Science Companies
In this webinar, Dr. Lucia Mokres breaks down the six major stakeholder categories relevant to most life science companies, and shares key strategies for closing the knowledge gap between founders and their market success.
Quality By Design: Remote Monitoring and eTMF Integration
Must-Know Finance Concepts for Life Sciences Valuations - Part II
This webinar discusses which asset valuation methodology is most used by big pharma to evaluate possible partners or acquisitions and an explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital, and present value.